497 |
Bivalirudin for the Best Overall Outcomes and Most Cath Lab Compatible |
Gregg W. Stone |
Nov. 02. 07 |
496 |
Pushing the Envelope for Bivalirudin Monotherapy: Design, Rationale, and Status of ISARREACT-4 and HORIZONS |
Adnan Kastrati |
Nov. 02. 07 |
495 |
ISAR-CHOICE-2: Randomized Trial of 75 mg vs 150 mg of Daily Clopidogrel in Patients Undergoing PCI |
Adnan Kastrati |
Nov. 02. 07 |
494 |
Dual Antiplatelet Therapy: How Long Should It Be Continued after DES Implantation? |
Cheol Whan Lee |
Nov. 02. 07 |
493 |
The Mini Crush Technique for the Treatment of Bifurcation and Trifurcation Coronary Lesions |
Alfredo R. Galassi |
Nov. 02. 07 |
492 |
Bifurcation Stenting: Implications of the Norfic Study |
Alan C. Yeung |
Nov. 02. 07 |
491 |
Insights into Bifurcation Strategies from 3D Imaging |
John Ormiston |
Oct. 26. 07 |
490 |
Vascular Functional Imaging of Coronary Artery |
Jong Hoon Koh |
Oct. 26. 07 |
489 |
Invasive Assessment of Microvascular Integrity in AMI Following Primary PCI |
Myeong-Ho Yoon |
Oct. 26. 07 |
488 |
Role of Cardiac CT in 2007 |
Kui-Hian Sim |
Oct. 26. 07 |